Last quarter (Q4 2022), Prescient Therapeutics Limited's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Prescient Therapeutics Limited's net income was AU$―. See Prescient Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	-	AU$ 7.10M	AU$ 5.43M	AU$ 4.50M	AU$ 5.55M	AU$ 3.61M
Operating Income	-	AU$ -7.10M	AU$ -5.43M	AU$ -4.50M	AU$ -5.55M	AU$ -3.61M
Net Non Operating Interest Income Expense	-	AU$ 37.64K	AU$ 55.67K	AU$ 66.17K	AU$ 68.81K	AU$ 122.96K
Other Income Expense	-	AU$ 1.94M	AU$ 1.22M	AU$ 1.11M	AU$ 1.68M	AU$ 909.33K
Pretax Income	-	AU$ -5.12M	AU$ -4.15M	AU$ -3.32M	AU$ -3.80M	AU$ -2.57M
Tax Provision	-	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -5.12M	AU$ -4.15M	AU$ -3.32M	AU$ -3.80M	AU$ -2.57M
Basic EPS	-	AU$ >-0.01	AU$ >-0.01	AU$ >-0.01	AU$ -0.02	AU$ -0.01
Diluted EPS	-	AU$ >-0.01	AU$ >-0.01	AU$ >-0.01	AU$ -0.02	AU$ -0.01
Basic Average Shares	-	AU$ 647.80M	AU$ 611.80M	AU$ 394.26M	AU$ 244.55M	AU$ 214.01M
Diluted Average Shares	-	AU$ 647.80M	AU$ 611.80M	AU$ 394.26M	AU$ 244.55M	AU$ 214.01M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	AU$ -5.12M	AU$ -4.15M	AU$ -3.32M	AU$ -3.80M	AU$ -2.57M
Normalized Income	-	AU$ -5.12M	AU$ -4.15M	AU$ -3.32M	AU$ -3.80M	AU$ -2.57M
Interest Expense	-	AU$ 6.53K	AU$ 10.62K	AU$ 4.19K	AU$ 3.30K	AU$ 2.20K
EBIT	-	AU$ -5.11M	AU$ -4.14M	AU$ -3.32M	AU$ -3.79M	AU$ -2.57M
EBITDA	-	AU$ -5.11M	AU$ -4.14M	AU$ -3.32M	AU$ -3.79M	AU$ -2.57M

Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing